In an asthma exacerbation treated with a beta-2 agonist inhaler, what distinguishes the bronchodilation mechanism from simple airway relaxation?

💡 Explanation

Beta-2 agonists stimulate bronchodilation via increased intracellular cAMP in smooth muscle cells, because the agonist binds to beta-2 receptors, activating adenylyl cyclase. Therefore, the outcome is smooth muscle relaxation, rather than a direct blockage or reduced mucus; those are secondary or unrelated effects.

• Why does the oxygen saturation in arterial blood sometimes fail to fully equilibrate with alveolar oxygen partial pressure during intense exercise, even when ventilation rate is high?
• If an elderly patient experiences increased muscle fatigue and reduced bone density due to diminished antioxidant capacity, which mechanism primarily accelerates this decline?
• Why does increased cerebral blood flow immediately after a concussion paradoxically exacerbate neuronal damage, despite appearing beneficial?
• Which downstream consequence results after sustained cardiac muscle cell hypoxia?
• A patient undergoing dialysis experiences a sudden drop in blood pressure. What causes the compensatory ADH release in response to this plasma volume shift?
• Why does an albino individual have a higher risk of sunburn when exposed to ultraviolet (UV) radiation, compared to someone with typical melanin production?